-
, as well as expertise in generating hypotheses on molecular mechanisms derived from omics data. Our lab develops technologies that integrate advanced imaging, computational analysis, and single-cell
-
infrastructure for species identification and monitoring (for example in the ARISE and DiSSCo projects). We run nature identification services processing many millions of images/month for users including
-
. The group comprises PhD-students and technicians all working on different aspects of complement regulation on human cells, employing techniques like ELISA, flow cytometry, confocal imaging, recombinant
-
address the limitations of existing vaccines, we focus on: structure-based antigen design – identifying and engineering key viral antigens to elicit cross-protective immune responses; viral vector
-
for the faster translation of novel treatment strategies into early phase clinical trials. Your role will be to investigate novel immunotherapy strategies using genetically engineered immune cells in various